Medytox Solutions, Inc.


Please Read and Agree to the Following before Proceeding

This website contains certain forward-looking information about us that is intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as “guidance”, “expect”, “will”, “may”, “anticipate”, “plan”, “estimate”, “project”, “intend”, “should”, “can”, “likely”, “could”, and similar expressions are intended to identify forward looking statements. These statements include statements about our plans, strategies and prospects. Forward-looking statements are not guarantees of performance. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot assure you that the expectations will prove to be correct. Important factors that could cause our actual results or performance to differ materially from the forward-looking statements include those set forth in the “Risk Factors” section of our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission, which filings are available on You should not place undue reliance on these forward-looking statements, which speak only as of the date they were placed on our website. Except to the extent required by applicable law or regulation, we undertake no obligation to update or publish revised forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Board of Directors

Benjamin Frank
Chairman of the Board

Benjamin Frank is a retired lawyer and businessman, with particular experience in healthcare, foreign trade, retail, business development and government. After practicing as an attorney, from 1962 to 1966 to he was a Senior Vice President and member of the Board of Directors of Allied Stores Corporation, which owned department stores and specialty stores, including Jordan Marsh, Brooks Brothers, Ann Taylor and others. He also served, from 1971 to 1987, as a Vice President and Trustee of North Shore University Hospital, currently North Shore University Hospital, Long Island Jewish Hospital System. Mr. Frank was appointed in February 2009 by former Florida governor Charlie Crist to the Board of the Health Care District of Palm Beach County and he served as Chair of the Board from October 2011 to February 2013.

Mr. Frank has managed and chaired several political campaigns, transition teams, task forces and committees involving federal, state and county governments. He served as a member of Governor Rockefeller's administration in New York State. President Reagan in 1980 selected Mr. Frank to Chair a special Transition Advisory Group focused on the revitalization of American cities. President Reagan also appointed him to two terms on his Advisory Committee for Trade Negotiations, in connection with which Mr. Frank chaired the committee that advised the President's administration in negotiating the first Free Trade Agreement with Canada. Mr. Frank earned a BS degree from Boston University and a JD from New York University School of Law.

Seamus Lagan
Chief Executive Officer

The Company has secured the services of Seamus Lagan through a consulting agreement with Alcimede LLC. Mr. Lagan brings over 20 years’ experience in the restructure, development and management of startup and small companies in both the private and public sector. Mr. Lagan was initially retained by the Company in May 2011 to find a new business opportunity for the Company and has been instrumental in forming the structure of and securing the funding for the Company to develop its current business plan. Mr. Lagan has been the CEO of the two main Subsidiaries of the Company since their inception, one that manages the sales and marketing efforts of the Company and the other that enters into agreement with or completes the acquisitions and development of Clinical Laboratories.

Christopher E. Diamantis

Christopher E. Diamantis has served since 1999 as Chairman and Chief Executive Officer of Integrated Financial Settlements, Inc., a structured settlement consulting firm in Tallahassee, Florida. He also has been, since April 2000, a director and managing partner of the Gabor Agency, Inc., a 63-year old Florida-based company specializing in investment and insurance planning for public employees and universities. Since 2007, Mr. Diamantis has been Chairman of Pro Bank Financial Holding Company, the parent of Pro Bank, a community bank in Tallahassee, Florida. He also has served, since 2011, as a director of Esquire Bank, a full-service, federally chartered savings bank in New York City. In addition, since 2007, Mr. Diamantis has been a director and partner in Counsel Financial Services, Inc., a specialty financial firm catering to the needs of the legal community and the largest non-bank lender to law firms in the United States. Mr. Diamantis graduated cum laude from Florida State University in 1990 with a BS degree in Finance. He is a past member of the Board of Governors of the Florida State University College of Business and past president of the National Structured Settlements Trade Association.

Michael L. Goldberg

Michael L. Goldberg is the managing director of Monarch Capital, LLC, a corporate consulting company primarily servicing small to mid-sized public and private companies. Prior to his position at Monarch, he served as acting CEO and president of IDO Security, Inc., from 2006 to 2013. Mr. Goldberg served as a director and CEO of Rx Medical Services Corp. (RXM), an American Stock Exchange-listed company, from May 1991 through June 2006. He has also worked with a number of private and public companies, assisting them in their formation and capital structure. He began his career as an Asper Fellow in the U.S. Attorney's office in 1974 with the Criminal Division of the Department of Justice in Washington, D.C. (Watergate prosecution team) before becoming an assistant district attorney. Mr. Goldberg was also a litigator in Philadelphia, where he maintained a private practice before he transitioned into a career in corporate restructuring. Mr. Goldberg has served as a director of both private and publicly traded companies and has served on audit and compensation committees.

Robert Lee

Robert Lee is the managing partner of Sheffield Investment Partners, a position he has held since 2010. From 2008 to 2010, Mr. Lee served as managing director of New Stream Capital, and from 2000 to 2007, he was managing director at CRT Capital Group. Mr. Lee is a board member of SL Investment Management. From 2001 to 2008, Mr. Lee served on the board of Springs Industries, and from 2008 until 2013, he served on the board of Springs Window Fashions. He currently serves on the Wake Forest School of Business board of visitors, of which he is also a former chairman.

Communications with Directors

The Board of Directors has adopted a process to facilitate written communications by stockholders or other interested parties to the entire Board of Directors or any individual member of the Board. Persons wishing to write to the Board of Directors of Medytox Solutions, Inc., or to a specific Director, should send correspondence to the Secretary of the Board of Directors at 400 South Australian Avenue, Suite 800, West Palm Beach, Florida 33401.

The Secretary of the Board of Directors will forward to the Directors all communications that, in his or her judgment, are appropriate for consideration by the Directors. Examples of communications that would not be appropriate for consideration by the Directors include commercial solicitations and matters not relevant to the stockholders, to the functioning of the Board of Directors, or to the affairs of Medytox Solutions, Inc. 

© 2015 Medytox Solutions Inc. All right reserved.
Website by Equisolve